Mirtazapine Orally Disintegrating Tablets Usp, 15 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 01)
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 76483-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Square Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.